| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $17,539,235 | 14 | 100 |
| Norwalk Leslie V | director | 0 | $0 | 2 | $557,600 | $-557,600 |
| RHOADS ANN D | director | 0 | $0 | 2 | $818,000 | $-818,000 |
| Kline Kyle | Senior Vice President, CFO | 0 | $0 | 2 | $2.03M | $-2.03M |
| TOBIN JAMES R | director | 0 | $0 | 1 | $2.24M | $-2.24M |
| Huller Kelly | SVP, GC, Corporate Secretary | 0 | $0 | 3 | $3.44M | $-3.44M |
| Davidar David D | director | 0 | $0 | 2 | $4.17M | $-4.17M |
| ZARRILLI STEPHEN T | director | 0 | $0 | 2 | $4.28M | $-4.28M |
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. …
Over the last 12 months, insiders at Globus Medical, Inc. have bought $0 and sold $17.54M worth of Globus Medical, Inc. stock.
On average, over the past 5 years, insiders at Globus Medical, Inc. have bought $0 and sold $12.69M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 615 shares for transaction amount of $33,136 was made by Douglas Robert Andrew (director) on 2020‑08‑24.
| 2026-09-15 | Sale | TOBIN JAMES R | director | 30,000 0.0222% | $74.58 | $2.24M | +2.08% | |
| 2026-08-18 | Sale | ZARRILLI STEPHEN T | director | 25,000 0.0187% | $87.04 | $2.18M | -11.50% | |
| 2026-06-05 | Sale | Davidar David D | director | 25,000 0.0187% | $80.76 | $2.02M | -1.46% | |
| 2026-02-25 | Sale | Huller Kelly | EVP, GC, Corporate Secretary | 20,000 0.0147% | $94.50 | $1.89M | -15.64% | |
| 2026-02-12 | Sale | Huller Kelly | EVP, GC, Corporate Secretary | 10,000 0.0075% | $87.67 | $876,700 | -6.63% | |
| 2026-01-08 | Sale | Norwalk Leslie V | director | 2,000 0.0016% | $101.10 | $202,200 | -12.35% | |
| 2026-01-08 | Sale | Kline Kyle | Senior Vice President, CFO | 3,594 0.0029% | $101.10 | $363,353 | -12.35% | |
| 2025-12-12 | Sale | Norwalk Leslie V | director | 4,000 0.0031% | $88.85 | $355,400 | -2.53% | |
| 2025-12-01 | Sale | Kline Kyle | Senior Vice President, CFO | 18,542 0.0139% | $90.00 | $1.67M | -5.41% | |
| 2025-11-25 | Sale | Huller Kelly | SVP, GC, Corporate Secretary | 7,500 0.0059% | $90.00 | $675,000 | -6.70% | |
| 2025-11-12 | Sale | Davidar David D | director | 25,000 0.019% | $86.00 | $2.15M | +0.27% | |
| 2025-11-11 | Sale | ZARRILLI STEPHEN T | director | 25,000 0.0187% | $84.29 | $2.11M | -0.15% | |
| 2025-11-10 | Sale | RHOADS ANN D | director | 2,000 0.0015% | $85.00 | $170,000 | -1.72% | |
| 2025-11-07 | Sale | RHOADS ANN D | director | 8,000 0.0079% | $81.00 | $648,000 | +1.25% | |
| 2025-09-15 | Sale | RHOADS ANN D | director | 10,000 0.0074% | $58.46 | $584,600 | +45.55% | |
| 2025-02-28 | Sale | RHOADS ANN D | director | 7,500 0.0046% | $78.68 | $590,100 | -21.53% | |
| 2025-01-10 | Sale | Pfeil Keith W | COO, CFO | 14,167 0.0105% | $88.29 | $1.25M | -27.61% | |
| 2024-12-02 | Sale | Huller Kelly | SVP, GC, Corporate Secretary | 2,500 0.0019% | $87.00 | $217,502 | -24.87% | |
| 2024-11-22 | Sale | Davidar David D | director | 13,512 0.01% | $85.00 | $1.15M | -25.87% | |
| 2024-11-22 | Sale | Lemaitre Dan | director | 1,097 0.0008% | $85.02 | $93,263 | -25.87% |
| Douglas Robert Andrew | director | 2005 0.0015% | $159,557.90 | 3 | 0 | +25.46% |
| Increased Positions | 282 | +45.05% | 19M | +16.32% |
| Decreased Positions | 282 | -45.05% | 19M | -15.99% |
| New Positions | 125 | New | 5M | New |
| Sold Out Positions | 54 | Sold Out | 5M | Sold Out |
| Total Postitions | 626 | 0% | 117M | +0.32% |
| Vanguard Group Inc | $925,882.00 | 9.47% | 10.61M | -103,146 | -0.96% | 2025-09-30 |
| Blackrock, Inc. | $919,559.00 | 9.4% | 10.53M | -230,169 | -2.14% | 2025-09-30 |
| Janus Henderson Group Plc | $659,345.00 | 6.74% | 7.55M | -654,262 | -7.97% | 2025-09-30 |
| Jpmorgan Chase & Co | $321,435.00 | 3.29% | 3.68M | +341,201 | +10.21% | 2025-09-30 |
| Sculptor Capital Lp | $305,550.00 | 3.13% | 3.5M | +739,312 | +26.78% | 2025-09-30 |
| State Street Corp | $302,199.00 | 3.09% | 3.46M | -11,766 | -0.34% | 2025-09-30 |
| Burgundy Asset Management Ltd. | $302,144.00 | 3.09% | 3.46M | -20,455 | -0.59% | 2025-09-30 |
| William Blair Investment Management, Llc | $246,113.00 | 2.52% | 2.82M | +414,134 | +17.22% | 2025-09-30 |
| Madison Avenue Partners, Lp | $222,455.00 | 2.28% | 2.55M | +836,015 | +48.83% | 2025-09-30 |
| Geneva Capital Management Llc | $181,928.00 | 1.86% | 2.08M | +1,151 | +0.06% | 2025-09-30 |